Massachusetts doctor develops preventative shot for Lyme disease
Dr. Mark Klempner, a professor of medicine at the University of Massachusetts, has developed a drug that may prevent Lyme disease from infecting humans. The drug, known as Lyme PrEP, was approved for its first human clinical trial by the Food and Drug Administration (FDA) at the end of 2020.” However, this older article concludes by saying:
“Assuming the tests go as planned, it’s predicted that Lyme PrEP could be available by 2023.”
There appears to be no further discussions as to the current status of the drug/vaccine.
